Tosi Umberto, Lara-Reyna Jacques, Chae John, Sepanj Roshann, Souweidane Mark M, Greenfield Jeffrey P
Department of Neurosurgery, Weill Cornell Medicine, New York, New York, USA.
Department of Neurosurgery, Weill Cornell Medicine, New York, New York, USA.
World Neurosurg. 2020 Apr;136:454-461.e1. doi: 10.1016/j.wneu.2020.01.148.
Chiari malformation (CM) is often comorbid with syringomyelia. The treatment of CM via posterior fossa decompression (PFD) may not improve syringomyelia in up to 40% of patients, based on historical cohorts. Management of these patients is problematic, as both reoperation and syrinx shunting have high failure rates in the long term.
We retrospectively reviewed our cases in which patients with CM type 1 or 1.5 and syringomyelia underwent PFD without postoperative improvement in syringomyelia. Symptomatology and radiographic measurements were collected at presentation and on the first and latest available postoperative scans and analyzed. We present 2 cases to illustrate the challenges in the management of these patients.
Our cohort consisted of 48 consecutive patients with CM and syringomyelia who underwent PFD. Of these, 41 patients had postoperative improvement in or resolution of syringomyelia. We subsequently studied the cohort of 7 patients who underwent PFD with (n = 5) or without (n = 2) durotomy and demonstrated worsening of syringomyelia following surgery. This cohort had mean (±SEM) preoperative syrinx area of 23.9 ± 10.0 mm. Postoperatively, the mean syrinx area increased to 40.5 ± 9.6 mm and 57.3 ± 12.5 mm on the first and latest postoperative scans available (P = 0.02), for an increase of 106.9% ± 94.4% and 186.0% ± 107.4% (P = 0.04). Presenting symptoms included occipital headache, paresthesias, visual deterioration, and paraspinal pain. On last follow-up (mean 13.9 ± 4.9 months), the majority of symptoms were resolved in this cohort, despite persistence of syringomyelia.
In this small cohort of unique patients, syrinx resolution was not achieved via decompression surgery. Despite "radiographic failure," good symptom control was achieved, with most patients remaining or becoming asymptomatic postoperatively, thus supporting our rationale for what has largely been a conservative approach in this population.
Chiari畸形(CM)常与脊髓空洞症合并存在。根据既往队列研究,通过后颅窝减压术(PFD)治疗CM,高达40%的患者脊髓空洞症可能无法改善。这些患者的治疗存在问题,因为再次手术和脊髓空洞分流术长期失败率都很高。
我们回顾性分析了1型或1.5型CM合并脊髓空洞症且接受PFD后脊髓空洞症未改善的患者病例。收集患者就诊时、术后首次及最新可获得扫描时的症状学和影像学测量数据并进行分析。我们展示2例病例以说明这些患者管理中的挑战。
我们的队列包括48例连续接受PFD的CM合并脊髓空洞症患者。其中,41例患者术后脊髓空洞症得到改善或消失。我们随后研究了7例接受PFD(5例行硬脑膜切开术,2例未行)且术后脊髓空洞症恶化的患者队列。该队列术前脊髓空洞平均面积为23.9±10.0mm²。术后,在首次和最新可获得的术后扫描中,脊髓空洞平均面积分别增加至40.5±9.6mm²和57.3±12.5mm²(P=0.02),增加了106.9%±94.4%和186.0%±107.4%(P=0.04)。就诊时症状包括枕部头痛、感觉异常、视力减退和脊柱旁疼痛。在最后一次随访时(平均13.9±4.9个月),尽管脊髓空洞症持续存在,但该队列大多数症状已缓解。
在这一小群特殊患者中,减压手术未能使脊髓空洞消失。尽管“影像学失败”,但实现了良好的症状控制,大多数患者术后仍无症状或症状消失,从而支持了我们在该人群中主要采取保守方法的理由。